ORIC Pharmaceuticals Inc’s recently made public that its Chief Financial Officer Piscitelli Dominic unloaded Company’s shares for reported $73298.0 on Dec 16 ’24. In the deal valued at $8.28 per share,8,851 shares were sold. As a result of this transaction, Piscitelli Dominic now holds 106,764 shares worth roughly $1.25 million.
Then, Multani Pratik S sold 8,850 shares, generating $73,293 in total proceeds. Upon selling the shares at $8.28, the Chief Medical Officer now owns 46,765 shares.
Before that, Chacko Jacob sold 24,660 shares. ORIC Pharmaceuticals Inc shares valued at $204,214 were divested by the PRESIDENT AND CEO at a price of $8.28 per share. As a result of the transaction, Chacko Jacob now holds 778,648 shares, worth roughly $9.09 million.
Wells Fargo initiated its ORIC Pharmaceuticals Inc [ORIC] rating to an Overweight in a research note published on October 31, 2024; the price target was $20. A number of analysts have revised their coverage, including Stifel’s analysts, who began to cover the stock in early September with a ‘”a Buy”‘ rating. Cantor Fitzgerald began covering ORIC with “an Overweight” recommendation on February 23, 2024. Wedbush started covering the stock on September 22, 2023. It rated ORIC as “an Outperform”.
Price Performance Review of ORIC
On Tuesday, ORIC Pharmaceuticals Inc [NASDAQ:ORIC] saw its stock jump 7.85% to $11.68. Over the last five days, the stock has gained 16.80%. ORIC Pharmaceuticals Inc shares have risen nearly 44.73% since the year began. Nevertheless, the stocks have risen 12.25% over the past one year. While a 52-week high of $16.65 was reached on 01/28/25, a 52-week low of $6.33 was recorded on 01/10/25. SMA at 50 days reached $9.16, while 200 days put it at $9.28.
Levels Of Support And Resistance For ORIC Stock
The 24-hour chart illustrates a support level at 10.87, which if violated will result in even more drops to 10.07. On the upside, there is a resistance level at 12.11. A further resistance level may holdings at 12.55. The Relative Strength Index (RSI) on the 14-day chart is 67.89, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.11, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 1.55%. Stochastics %K at 87.93% indicates the stock is a selling.
How much short interest is there in ORIC Pharmaceuticals Inc?
A steep rise in short interest was recorded in ORIC Pharmaceuticals Inc stocks on 2025-01-15, dropping by -0.69 million shares to a total of 10.52 million shares. Yahoo Finance data shows the prior-month short interest on 2024-12-13 was 11.21 million shares. There was a decline of -6.54%, which implies that there is a negative sentiment for the stock.
